The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Condition: Refractory/Relapsed Autoimmune Hemolytic Anemia Intervention: Drug: Zanubrutinib Sponsor: Institute of Hematology & Blood Diseases Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Autoimmune and Inflammatory Response Biomarkers in Fabry Disease
Condition: Fabry Disease Intervention: Sponsors: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal; Fundación Mutua Madrileña Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials